At Nemours, we promise to do whatever it takes to treat children as we would our own. When your child comes to Nemours, we know you’re placing your trust in us. This trust and our dedication to improving the health of your child is what inspires us to provide exceptional care and the most satisfying experience possible.
Stories: Patients and families share their experiences.
Quality & Safety: Learn how we track and measure the success of our care.
- Acute Lymphoblastic Leukemia (ALL) Survival Rate
- Giving Even the Sickest Children the Best Chance at Life
Patient Satisfaction: See what families say about our care.
News & Recognition
- Alfred I. duPont Hospital for Children Wins Research Grant From Hyundai Hope On Wheels
- Caitlin Robb Foundation Donates to Cancer Research
- Carper, Carney Announce $4.6 Million for Cancer Research
- Dr. Kolb Appointed to Children's Oncology Group Scientific Council
- Component of Turmeric Shows Promise in Brain Tumor Treatment
- D.O. Believe Foundation Donates $25,000 to Nemours Childhood Cancer Research
- Delaware Health Sciences Alliance Awards Grant to Nemours Center for Childhood Cancer Research
- Hyundai Hope On Wheels Awards $75,000 Hyundai Scholar Grant For Pediatric Cancer Program
- Hyundai Hope on Wheels Awards Nemours $100,000 Grant
- Jeremy P. Wilson Foundation Donates $20,000 to Nemours Cancer Research
- Joint Cancer Program of Nemours and Wolfson Children's Receives Achievement Award
- Kids' Runway for Research gives $9,000 to Child Cancer Research
- Nanotechnology for Drug Delivery Shows Promise in Treatment of Pediatric Leukemia
- Nemours Receives Donation to Support Cancer Research
- Nemours Researchers Uncover New Evidence of Harmfulness of Secondhand Smoke
- Students Donate Art Work to Nemours/Alfred I. duPont Hospital for Children
- U.S. News & World Report 2011-2012
Carper, Carney Announce $4.6 Million for Cancer Research
Today, U.S. Senator Tom Carper (D-Del) and U.S. Representative John Carney (D-Del) announced $4.6 million in funding from the National Cancer Institute at the National Institutes of Health for the Community Clinical Oncology Program (CCOP). CCOP is a network for testing and validating medical interventions against cancer, and for delivering the benefits of scientific discovery to the public and community physicians.
Carper and Carney were joined by some of the representatives from the program's affiliates at Christiana Care's Helen F. Graham Cancer Center for the announcement. The affiliates are Christiana Care Health System, Nemours/Alfred I. duPont Hospital for Children, Beebe Medical Center, Union Hospital of Cecil County in Elkton, MD, and Cooper University Hospital in Voorhees, NJ.
The CCOP program received a three-year grant for $4,691,802 that will enable them to develop and administer research protocols to fight cancer. The research money will be used to fund cancer prevention trials, cancer treatment trials, and cancer control trials.
"The key to getting better results in our health care system is better coordination of care and using early screening to prevent and treat illness as early as possible," said Senator Carper. "This grant will enable the region's hospitals to study new ways to detect, treat, and prevent cancer while also providing patients who participate in the studies with innovative, top-notch care. This is a promising step in cancer research for both the patients and healthcare providers."
"Investing in cancer research saves lives and strengthens our economy," Senator Coons said. "Funding cutting-edge scientific and medical research is how we will cure our way out of this tough economy and deliver the next generation of treatments and cures that will ease the pain of Delawareans across the state."
"Christiana Care and its partners have done an outstanding job developing the Community Clinical Oncology Program into a world-class resource for cancer research," said Congressman Carney, a member of the Delaware Cancer Consortium Advisory Council. "The funding announced today will give more Delawareans access to cutting-edge research and technology in the fight against cancer. I'm proud to continue my support for the significant progress being made by Christiana Care, the Delaware Cancer Consortium, and partners throughout the state."
"Through this National Cancer Institute grant, people in our area will continue to have access to many cancer trials and our doctors and researcher coordinators will be better equipped to treat and prevent this disease," said Nicholas Petrelli, MD, medical director of Christiana Care's Helen F. Graham Cancer Center.
"As we know, government funding for pediatric cancer research is just a fraction — a mere 4% — of what is spent on adult cancer research. To get the most out of the funding we receive, we need to work together with our adult oncology colleagues to maintain an efficient and productive clinical research infrastructure," said Andy Kolb, MD, director of the Nemours Center for Cancer and Blood Disorders. "Collaborative research offers hope for better treatments and cures for all cancers."
About Community Clinical Oncology Program
The national CCOP began in 1983 and Christiana Care Health System began participation in 1987. From June 1987 through May 2012, a total of 7,276 individuals participated in an NCI designated clinical trial through Delaware's program. This includes 4,471 individuals accrued to treatment trials and 2,805 accrued to prevention and cancer control trials.
These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists' knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts.
The Delaware CCOP's accrual rate is one of the top three (out of 49) in the U.S.